Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Viral Mucosal Reprogramming — Stella

Home/Asthma/Viral Mucosal Reprogramming

View on ClinicalTrials.gov

Recruiting

Back to Asthma trials

Viral Mucosal Reprogramming

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Texas Medical Branch, Galveston, Texas

Key details

Phase

Safety & dosing

Sponsor

The University of Texas Medical Branch, Galveston

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~75 participants

Started

April 2023

Primary completion

May 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years – 60 Years

Last updated January 2025